[1]FUJIWARA N, FRIEDMAN SL, GOOSSENS N, et al.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine[J].J Hepatol, 2017.[Epub ahead of print]
|
[2]LIANG XE, WANG Y, HOU JL.Quantitative assessment of liver fibrosis:invasive or non-invasive?[J].J Clin Hepatol, 2015, 31 (3) :317-321. (in Chinese) 梁携儿, 汪艳, 侯金林.肝纤维化定量诊断:有创还是无创?[J].临床肝胆病杂志, 2015, 31 (3) :317-321.
|
[3]DU JH, NAN YM.Novel molecular diagnostic markers for liver fibrosis[J].J Clin Hepatol, 2017, 33 (3) :445-450. (in Chinese) 杜静华, 南月敏.肝纤维化新型分子诊断标志物[J].临床肝胆病杂志, 2017, 33 (3) :445-450.
|
[4]HUANG CI, HUANG CF, YEH ML, et al.Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patients[J].Kaohsiung J Med Sci, 2017, 33 (8) :394-399.
|
[5]Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].J Clin Hepatol, 2011, 27 (1) :I-XVI. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010版) [J].临床肝胆病杂志, 2011, 27 (1) :I-XVI.
|
[6]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for hepatitis C:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1961-1979. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.丙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1961-1979.
|
[7]STERLING RK, LISSEN E, CLUMECK N, et al.Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV confection[J].Hepatology, 2006, 43 (6) :1317-1325.
|
[8]WAI CT, GREENSON JK, FONTANA RJ, et al.A simple noninvasive indexcan predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J].Hepatology, 2003, 38 (2) :518-526.
|
[9]Chinese Society of Infectious Diseases and Parasitology, Chinese Society of Hepatology, Chinese Medical Association.Prevention and treatment of viral hepatitis[J].Chin J Infect Dis, 2001, 19 (1) :56-62. (in Chinese) 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) :56-62.
|
[10]ZHANG Q, LIU J, GAO XH.Detection of miRNA-122 expression in serum exosome in patients with HCV infection and its clinical significance[J].Chin J Clin Infect Dis, 2016, 9 (5) :439-443. (in Chinese) 张庆, 刘杰, 高晓红.HCV感染者中血清外泌体miRNA-122的检测及其临床意义[J].中华临床感染病杂志, 2016, 9 (5) :439-443.
|
[11]KUNO A, IKEHARA Y, TANAKA Y, et al.A serum“sweetdoughnut”protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis[J].Sci Rep, 2013, 3:1065-1073.
|
[12]MA YH, XING HC.Advances of microRNA on liver fibrosis[J/CD].Chin J Liver Dis:Electronic Edition, 2017, 9 (2) :1-4. (in Chinese) 马艳华, 邢卉春.microRNAs在肝纤维化中的研究进展[J/CD].中国肝脏病杂志:电子版, 2017, 9 (2) :1-4.
|
[13]MAK KM, MEI R.Basement membrane type IV collagen and laminin:an overview of their biology and value as fibrosisbiomarkers of liver disease[J].Anat Rec (Hoboken) , 2017, 300 (8) :1371-1390.
|
[14]MA YH, HAN M, FENG SH, et al.Differential expression of plasma microRNA in patients with HBV-related liver fibrosis[J/CD].Chin J Liver Dis:Electronic Edition, 2017, 9 (1) :20-26. (in Chinese) 马艳华, 韩铭, 冯胜虎, 等.HBV相关肝纤维化患者血浆microRNA的差异表达[J/CD].中国肝脏病杂志:电子版, 2017, 9 (1) :20-26.
|
[15]MU MY, LI Y, YANG WF, et al.Research progress of microRNA-122 in hepatitis B virus infection and related diseases[J].J Med Res, 2015, 44 (1) :154-158. (in Chinese) 穆茂媛, 李滢, 杨方万, 等.microRNA-122在乙型肝炎病毒感染及相关疾病中的研究进展[J].医学研究杂志, 2015, 44 (1) :154-158.
|
[16]JIANG DF, XING TJ, HUANG JX, et al.Expression and clinical significance of miR-122 and 29 in the hepatitis B virus-related liver disease[J/CD].Chin J Clinicians:Electronic Edition, 2013, 7 (3) :1085-1089. (in Chinese) 姜丹凤, 邢同京, 黄俊星, 等.微小RNA-122和29在乙型肝炎病毒感染相关肝病中的表达及临床意义[J/CD].中华临床医师杂志:电子版, 2013, 7 (3) :1085-1089.
|
[17]NAKAMURA M, KANDA T, JIANG X, et al.Serum microRNA-122 and Wisteria floribundaagglutinin-positive Mac-2 binding protein areuseful tools for liquid biopsy of the patientswith hepatitis B virus and advanced liverfibrosis[J].PLo S One, 2017, 12 (5) :e0177302.
|
[18]HASEGAWA K, TAKATA R, NISHIKAWA H, et al.Impact of wisteria floribunda agglutinin-positive Mac-2-binding protein in patients with hepatitis C virus-related compensated liver cirrhosis[J].Int J Mol Sci, 2016, 17 (9) :1500.
|